Merus N.V.: New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...